Presidential debate highlights opioid epidemic
Yahoo Finance's Adriana Belmonte breaks down the presidential hopefuls views on the opioid epidemic and how the government should handle drug-makers.
Advertisement
Recommended Stories
A Once-in-a-Decade Opportunity: 3 Magnificent Dividend Stocks Down Between 19% and 28% to Buy Now and Hold Forever
These three low-volatility, dividend-growth stocks offer the potential to rebound while trading near decade-low valuations.
Motley FoolFort Worth's tallest building sells for just $12.3M at auction in stunning price drop
The tallest building in Fort Worth, Texas, has been bought by a bank for $12.3 million, three years after it sold $137.5 million. Burnett Plaza has 40 stories and is 567 feet tall.
Fox BusinessAre Stocks Going to Crash? This Forecasting Tool Hasn't Been Wrong in 65 Years, and It Has a Sobering Message for Wall Street
This historically flawless predictive tool has accurately foreshadowed what's to come for the U.S. economy since 1959.
Motley FoolUtility stocks are on fire — here are Wall Street analysts' top picks
Utility stocks are outperforming the broader markets. Here's a look at three top picks from analysts.
Yahoo FinanceWarren Buffett Sold Apple and Paramount. Here's What He's Buying Instead.
The Oracle of Omaha keeps selling more stocks than he's buying. Here's what's on his shopping list.
Motley FoolFact or Fiction: Congress Stole From Social Security and Should Return the Money It's Taken, With Interest
Did lawmakers really pilfer Social Security's piggy bank? Here's the truth.
Motley Fool1 Stock (Not Nvidia) Could Be a Massive Winner From Data Center AI
This company also combines a powerful portfolio of both chips and software, not unlike what Nvidia is building.
Motley FoolQuantumScape Making Big Moves: Time to Buy Before It Skyrockets?
The battery start-up might reach its ambitions sooner than expected.
Motley FoolShould You Buy Nvidia Stock Before May 22?
Nvidia is scheduled to make a significant investor announcement that could have enormous implications for the stock price.
Motley Fool